Turn Up the Lex Appeal

Schematic illustration of the LexA-based yeast two-hybrid interaction. Source: OriGene Technologies, Inc. 97/98 Catalog. Reprinted with permission. The DupLEX-ATM system from OriGene Technologies is a LexA-based two-hybrid assay for the detection of protein-protein interactions in vivo (J. Gyuris et al., Cell 75:791-803, 1993). The LexA system is conceptually similar to the prototypical GAL4-based two-hybrid system, both of which are based on the bipartate nature of yeast transcriptional acti

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Schematic illustration of the LexA-based yeast two-hybrid interaction. Source: OriGene Technologies, Inc. 97/98 Catalog. Reprinted with permission. The DupLEX-ATM system from OriGene Technologies is a LexA-based two-hybrid assay for the detection of protein-protein interactions in vivo (J. Gyuris et al., Cell 75:791-803, 1993). The LexA system is conceptually similar to the prototypical GAL4-based two-hybrid system, both of which are based on the bipartate nature of yeast transcriptional activators. These protein complexes can be used to activate transcription when their two domains (DNA binding and transcriptional activator domains) are brought into proximity. In two-hybrid systems, this is mediated by the presence of interacting proteins that have been fused to one of the two domains on separate vectors--the so-called bait vector-- which contains the DNA-binding (LexA) domain, and the target vector, which contains the transcriptional activator, (B42) domain (S. Fields and O. Song, Nature, 340:245-247, 1989; C.T. Chien et al., Proceedings of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Deborah Wilkinson

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo